These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21247359)

  • 1. Improving progression-free and overall survival in patients with cancer: a potential role for bisphosphonates.
    Lipton A
    Expert Opin Pharmacother; 2011 Apr; 12(5):749-62. PubMed ID: 21247359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential anticancer properties of bisphosphonates.
    Neville-Webbe HL; Gnant M; Coleman RE
    Semin Oncol; 2010 Jun; 37 Suppl 1():S53-65. PubMed ID: 20682373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are bisphosphonates the suitable anticancer drugs for the elderly?
    Santini D; Fratto ME; Galluzzo S; Vincenzi B; Tonini G
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):83-94. PubMed ID: 18692400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of bisphosphonates: promising preclinical evidence.
    Guise TA
    Cancer Treat Rev; 2008; 34 Suppl 1():S19-24. PubMed ID: 18486348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates.
    Aft R; Perez JR; Raje N; Hirsh V; Saad F
    Crit Rev Oncol Hematol; 2012 May; 82(2):233-48. PubMed ID: 21683613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates as anticancer therapy for early breast cancer.
    Mahtani R; Jahanzeb M
    Clin Breast Cancer; 2010 Oct; 10(5):359-66. PubMed ID: 20920980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential application of zoledronic acid as anticancer therapy in patients with non-small-cell lung cancer.
    Mahtani R; Khan R; Jahanzeb M
    Clin Lung Cancer; 2011 Jan; 12(1):26-32. PubMed ID: 21273176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D; Henschke P; Possinger K
    Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bone-targeted agents on cancer progression and mortality.
    Coleman R; Gnant M; Morgan G; Clezardin P
    J Natl Cancer Inst; 2012 Jul; 104(14):1059-67. PubMed ID: 22752060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects and anticancer applications of bisphosphonates.
    Morgan G; Lipton A
    Semin Oncol; 2010 Oct; 37 Suppl 2():S30-40. PubMed ID: 21111246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous bisphosphonates for breast cancer: impact on patient outcomes and scientific concepts.
    Gnant M
    Breast Dis; 2011; 33(2):71-81. PubMed ID: 22142663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer evidence for zoledronic acid across the cancer continuum.
    Costa L; Harper P; Coleman RE; Lipton A
    Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S31-7. PubMed ID: 21353179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of bisphosphonates in cancer patients.
    Wu S; Dahut WL; Gulley JL
    Acta Oncol; 2007; 46(5):581-91. PubMed ID: 17562434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential anticancer properties of bisphosphonates: insights from preclinical studies.
    Clezardin P
    Anticancer Agents Med Chem; 2012 Feb; 12(2):102-13. PubMed ID: 21864232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid: multiplicity of use across the cancer continuum.
    Lipton A
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):999-1012. PubMed ID: 21806323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates in breast cancer: antitumor effects.
    Aft R
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):292-9. PubMed ID: 21558988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
    Lipton A
    Cancer Treat Rev; 2008; 34 Suppl 1():S25-30. PubMed ID: 18486347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New role for an established drug? Bisphosphonates as potential anticancer agents.
    Koul HK; Koul S; Meacham RB
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):111-9. PubMed ID: 21876554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.
    Aft R
    Clin Adv Hematol Oncol; 2011 Mar; 9(3):194-205. PubMed ID: 21475125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.